INS and type 1 diabetes mellitus: Bearing in mind that T1D is an autoimmune disease during which the immune system attacks the pancreatic β-cells and insulin auto-antigens, researchers have attempted to identify an immunomodulatory agent for the prevention or treatment of this disease.